G1 Therapeutics EPS - Earnings per Share 2016-2024 | GTHX
G1 Therapeutics eps - earnings per share from 2016 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| G1 Therapeutics Annual EPS |
| 2023 |
$-0.93 |
| 2022 |
$-3.38 |
| 2021 |
$-3.54 |
| 2020 |
$-2.62 |
| 2019 |
$-3.27 |
| 2018 |
$-2.56 |
| 2017 |
$-3.57 |
| 2016 |
$-23.33 |
| 2015 |
$-16.13 |
| G1 Therapeutics Quarterly EPS |
| 2024-06-30 |
$-0.10 |
| 2024-03-31 |
$-0.20 |
| 2023-12-31 |
$-0.19 |
| 2023-09-30 |
$-0.35 |
| 2023-06-30 |
$0.14 |
| 2023-03-31 |
$-0.53 |
| 2022-12-31 |
$-0.72 |
| 2022-09-30 |
$-0.59 |
| 2022-06-30 |
$-0.92 |
| 2022-03-31 |
$-1.15 |
| 2021-12-31 |
$-0.95 |
| 2021-09-30 |
$-1.00 |
| 2021-06-30 |
$-0.94 |
| 2021-03-31 |
$-0.65 |
| 2020-12-31 |
$-0.66 |
| 2020-09-30 |
$-0.31 |
| 2020-06-30 |
$-0.83 |
| 2020-03-31 |
$-0.82 |
| 2019-12-31 |
$-0.95 |
| 2019-09-30 |
$-0.86 |
| 2019-06-30 |
$-0.82 |
| 2019-03-31 |
$-0.64 |
| 2018-12-31 |
$-0.63 |
| 2018-09-30 |
$-0.59 |
| 2018-06-30 |
$-0.64 |
| 2018-03-31 |
$-0.70 |
| 2017-12-31 |
$9.31 |
| 2017-09-30 |
$-0.55 |
| 2017-06-30 |
$-1.09 |
| 2017-03-31 |
$-11.24 |
| 2016-12-31 |
$0.00 |
| 2016-09-30 |
$-5.21 |
| 2016-06-30 |
$-5.63 |
| 2015-12-31 |
$0.00 |
